Extracorporeal membrane oxygenation combined with continuous renal replacement therapy for the treatment of severe burns: current status and challenges

Abstract

Severe burns often cause various systemic complications and multiple organ dysfunction syndrome, which is the main cause of death. The lungs and kidneys are vulnerable organs in patients with multiple organ dysfunction syndrome after burns. Extracorporeal membrane oxygenation (ECMO) and continuous renal replacement therapy (CRRT) have been gradually applied in clinical practice and are beneficial for severe burn patients with refractory respiratory failure or renal dysfunction. However, the literature on ECMO combined with CRRT for the treatment of severe burns is limited. Here, we focus on the current status of ECMO combined with CRRT for the treatment of severe burns and the associated challenges, including the timing of treatment, nutrition support, heparinization and wound management, catheter-related infection and drug dosing in CRRT. With the advancement of medical technology, ECMO combined with CRRT will be further optimized to improve the outcomes of patients with severe burns.

Keywords

Severe burns / Extracorporeal membrane oxygenation / Continuous renal replacement therapy / Multiple organ dysfunction syndrome / Acute kidney injury / Acute respiratory distress syndrome

References

[1] Kallinen O, Maisniemi K, Böhling T, Tukiainen E, Koljonen V. Multiple organ failure as a cause of death in patients with severe burns. J Burn Care Res. 2012; 33: 206-11.

[2] Saffle JR, Sullivan JJ, Tuohig GM, Larson CM. Multiple organ failure in patients with thermal injury. Crit Care Med. 1993; 21: 1673-83.

[3] White A, Fan E. What is ECMO? Am J Respir Crit Care Med. 2016; 193: 9-10.

[4] Fletcher K, Chapman R, Keene S. An overview of medical ECMO for neonates. Semin Perinatol. 2018; 42: 68-79.

[5] Bein T, Aubron C, Papazian L. Focus on ECMO and ECCO2R in ARDS patients. Intensive Care Med. 2017; 43: 1424-6.

[6] Rao P, Khalpey Z, Smith R, Burkhoff D, Kociol RD. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest. Circ Heart Fail. 2018; 11:e004905. doi: 10.1161/CIRCHEARTFAILURE.118.004905.

[7] Xie A, Phan K, Tsai YC, Yan TD, Forrest P. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest: a meta-analysis. J Cardiothorac Vasc Anesth. 2015; 29: 637-45.

[8] Sun T, Guy A, Sidhu A, Finlayson G, Grunau B, Ding L, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support. J Crit Care. 2018; 44: 31-8.

[9] Karagiannidis C, Brodie D, Strassmann S, Stoelben E, Philipp A, Bein T, et al. Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med. 2016; 42: 889-96.

[10] Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016; 20: 387. doi: 10.1186/s13054-016-1570-4.

[11] Brusselaers N, Monstrey S, Colpaert K, Decruyenaere J, Blot SI, Hoste EA. Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis. Intensive Care Med. 2010; 36: 915-25.

[12] Chung KK, Coates EC, Smith DJ Jr, Karlnoski RA, Hickerson WL, Arnold-Ross AL, et al. High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial. Crit Care. 2017; 21: 289. doi: 10.1186/s13054-017-1878-8.

[13] Karkar A, Ronco C. Prescription of CRRT: a pathway to optimize therapy. Ann Intensive Care. 2020; 10: 32. doi: 10.1186/s13613-020-0648-y.

[14] Romagnoli S, Ricci Z, Ronco C. CRRT for sepsis-induced acute kidney injury. Curr Opin Crit Care. 2018; 24: 483-92.

[15] Vaara ST, Bellomo R. Extra-renal indications for continuous renal replacement therapy. Contrib Nephrol. 2018; 194: 90-8.

[16] Hollingsed TC, Saffle JR, Barton RG, Craft WB, Morris SE. Etiology and consequences of respiratory failure in thermally injured patients. Am J Surg. 1993; 166: 592-6.

[17] Dancey DR, Hayes J, Gomez M, Schouten D, Fish J, Peters W, et al. ARDS in patients with thermal injury. Intensive Care Med. 1999; 25: 1231-6.

[18] Ricci Z, Romagnoli S, Ronco C. Renal replacement therapy. F1000Res. 2016; 5: F1000 Faculty Rev-103. doi: 10.12688/f1000research.6935.1.

[19] Helanterä I, Koljonen V, Finne P, Tukiainen E, Gissler M. The risk for end-stage renal disease is increased after burn. Burns. 2016; 42: 316-21.

[20] Chen H, Yu RG, Yin NN, Zhou JX. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review. Crit Care. 2014; 18: 675. doi: 10.1186/s13054-014-0675-x.

[21] Ostermann M, Connor M Jr, Kashani K. Continuous renal replacement therapy during extracorporeal membrane oxygenation: why, when and how? Curr Opin Crit Care. 2018; 24: 493-503.

[22] Askenazi DJ, Selewski DT, Paden ML, Cooper DS, Bridges BC, Zappitelli M, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol. 2012; 7: 1328-36.

[23] Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2014; 97: 610-6.

[24] Kielstein JT, Heiden AM, Beutel G, Gottlieb J, Wiesner O, Hafer C, et al. Renal function and survival in 200 patients undergoing ECMO therapy. Nephrol Dial Transplant. 2013; 28: 86-90.

[25] Kilburn DJ, Shekar K, Fraser JF. The complex relationship of extracorporeal membrane oxygenation and acute kidney injury: causation or association? Biomed Res Int. 2016; 2016: 1094296. doi: 10.1155/2016/1094296.

[26] Chelazzi C, Villa G, Mancinelli P, De Gaudio AR, Adembri C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit Care. 2015; 19: 26. doi: 10.1186/s13054-015-0741-z.

[27] Shekar K, Fraser JF. Can timely ECMO initiation mitigate pre-ECMO risk factors for acute kidney injury? Ann Thorac Surg. 2014; 98: 1523. doi: 10.1016/j.athoracsur.2014.05.055.

[28] van den Akker JP, Egal M, Groeneveld AB.Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: a systematic review and meta-analysis. Crit Care. 2013; 17: R98. doi: 10.1186/cc12743.

[29] Dado DN, Ainsworth CR, Thomas SB, Huang B, Piper LC, Sams VG, et al. Outcomes among patients treated with renal replacement therapy during extracorporeal membrane oxygenation: a single-center retrospective study. Blood Purif. 2020; 49: 341-7.

[30] Fleming GM, Askenazi DJ, Bridges BC, Cooper DS, Paden ML, Selewski DT, et al. A multicenter international survey of renal supportive therapy during ECMO: the kidney intervention during extracorporeal membrane oxygenation (KIDMO) group. ASAIO J. 2012; 58: 407-14.

[31] Gadepalli SK, Selewski DT, Drongowski RA, Mychaliska GB. Acute kidney injury in congenital diaphragmatic hernia requiring extracorporeal life support: an insidious problem. J Pediatr Surg. 2011; 46: 630-5.

[32] Smith AH, Hardison DC, Worden CR, Fleming GM, Taylor MB. Acute renal failure during extracorporeal support in the pediatric cardiac patient. ASAIO J. 2009; 55: 412-6.

[33] Seczyńska B, Królikowski W, Nowak I, Jankowski M, Szułdrzyński K, Szczeklik W. Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations. Ther Apher Dial. 2014; 18: 523-34.

[34] Suga N, Matsumura Y, Abe R, Hattori N, Nakada TA, Oda S. A safe procedure for connecting a continuous renal replacement therapy device into an extracorporeal membrane oxygenation circuit. J Artif Organs. 2017; 20: 125-31.

[35] Santhanakrishnan A, Nestle T, Moore BL, Yoganathan AP, Paden ML. Design and validation of a diaphragm pump for pediatric CRRT during ECMO. Int J Artif Organs. 2013; 36: 892-9.

[36] de Tymowski C, Augustin P, Houissa H, Allou N, Montravers P, Delzongle A, et al. CRRT connected to ECMO: managing high pressures. ASAIO J. 2017; 63: 48-52.

[37] Rubin S, Poncet A, Wynckel A, Baehrel B. How to perform a haemodialysis using the arterial and venous lines of an extracorporeal life support. Eur J Cardiothorac Surg. 2010; 37: 967-8.

[38] Ricci Z, Ronco C, Picardo S. CRRT in series with extracorporeal membrane oxygenation in pediatric patients. Kidney Int. 2010; 77: 469-70.

[39] Yetimakman AF, Tanyildiz M, Kesici S, Kockuzu E, Bayrakci B. Continuous renal replacement therapy applications on extracorporeal membrane oxygenation circuit. Indian J Crit Care Med. 2017; 21: 355-8.

[40] Walker PF, Buehner MF, Wood LA, Boyer NL, Driscoll IR, Lundy JB, et al. Diagnosis and management of inhalation injury: an updated review. Crit Care. 2015; 19: 351. doi: 10.1186/s13054-015-1077-4.

[41] Tiruvoipati R, Moorthy T, Balasubramanian SK, Platt V, Peek GJ. Extracorporeal membrane oxygenation and extracorporeal albumin dialysis in pediatric patients with sepsis and multi-organ dysfunction syndrome. Int J Artif Organs. 2007; 30: 227-34.

[42] Ostermann M, Joannidis M, Pani A, Floris M, De Rosa S, Kellum JA, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif. 2016; 42: 224-37.

[43] Schmidt M, Bailey M, Kelly J, Hodgson C, Cooper DJ, Scheinkestel C, et al. Impact of fluid balance on outcome of adult patients treated with extracorporeal membrane oxygenation. Intensive Care Med. 2014; 40: 1256-66.

[44] Dalia AA, Ortoleva J, Fiedler A, Villavicencio M, Shelton K, Cudemus GD. Extracorporeal membrane oxygenation is a team sport: institutional survival benefits of a formalized ECMO team. J Cardiothorac Vasc Anesth. 2019; 33: 902-7.

[45] Langer T, Santini A, Bottino N, Crotti S, Batchinsky AI, Pesenti A, et al. Awake extracorporeal membrane oxygenation (ECMO): pathophysiology, technical considerations, and clinical pioneering. Crit Care. 2016; 20: 150. doi: 10.1186/s13054-016-1329-y.

[46] Chlebowski MM, Baltagi S, Carlson M, Levy JH, Spinella PC. Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO. Crit Care. 2020; 24: 19. doi: 10.1186/s13054-020-2726-9.

[47] Kennedy JD, Thayer W, Beuno R, Kohorst K, Kumar AB. ECMO in major burn patients: feasibility and considerations when multiple modes of mechanical ventilation fail. Burns Trauma. 2017; 5: 20. doi: 10.1186/s41038-017-0085-9.

[48] Asmussen S, Maybauer DM, Fraser JF, Jennings K, George S, Keiralla A, et al. Extracorporeal membrane oxygenation in burn and smoke inhalation injury. Burns. 2013; 39: 429-35.

[49] Chung KK, Coates EC, Hickerson WL, Arnold-Ross AL, Caruso DM, Albrecht M, et al. Renal replacement therapy in severe burns: a multicenter observational study. J Burn Care Res. 2018; 39: 1017-21.

[50] Peng Y, Yuan Z, Li H. Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis. Burns. 2005; 31: 623-8.

[51] Askegard-Giesmann JR, Besner GE, Fabia R, Caniano DA, Preston T, Kenney BD. Extracorporeal membrane oxygenation as a lifesaving modality in the treatment of pediatric patients with burns and respiratory failure. J Pediatr Surg. 2010; 45: 1330-5.

[52] Pu Q, Qian J, Tao W, Yang A, Wu J, Wang Y. Extracorporeal membrane oxygenation combined with continuous renal replacement therapy in cutaneous burn and inhalation injury caused by hydrofluoric acid and nitric acid. Medicine (Baltimore). 2017; 96: e8972. doi: 10.1097/MD.0000000000008972.

[53] Hsu PS, Tsai YT, Lin CY, Chen SG, Dai NT, Chen CJ, et al. Benefit of extracorporeal membrane oxygenation in major burns after stun grenade explosion: experience from a single military medical center. Burns. 2017; 43: 674-80.

[54] Ainsworth CR, Dellavolpe J, Chung KK, Cancio LC, Mason P. Revisiting extracorporeal membrane oxygenation for ARDS in burns: a case series and review of the literature. Burns. 2018; 44: 1433-8.

[55] Szentgyorgyi L, Shepherd C, Dunn KW, Fawcett P, Barker JM, Exton P, et al. Extracorporeal membrane oxygenation in severe respiratory failure resulting from burns and smoke inhalation injury. Burns. 2018; 44: 1091-9.

[56] Dadras M, Wagner JM, Wallner C, Huber J, Buchwald D, Strauch J, et al. Extracorporeal membrane oxygenation for acute respiratory distress syndrome in burn patients: a case series and literature update. Burns Trauma. 2019; 7: 28. doi: 10.1186/s41038-019-0166-z.

[57] Rae L, Fidler P, Gibran N. The physiologic basis of burn shock and the need for aggressive fluid resuscitation. Crit Care Clin. 2016; 32: 491-505.

[58] Latenser BA. Critical care of the burn patient: the first 48 hours. Crit Care Med. 2009; 37: 2819-26.

[59] Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. Current treatment of severely burned patients. Ann Surg. 1996; 223: 14-25.

[60] Gacto-Sanchez P. Surgical treatment and management of the severely burn patient: review and update. Med Intensiva. 2017; 41: 356-64.

[61] Clark A, Imran J, Madni T, Wolf SE. Nutrition and metabolism in burn patients. Burns Trauma. 2017; 5: 11. doi: 10.1186/s41038-017-0076-x.

[62] Moreira E, Burghi G, Manzanares W. Update on metabolism and nutrition therapy in critically ill burn patients. Med Intensiva. 2018; 42: 306-16.

[63] Porter C, Tompkins RG, Finnerty CC, Sidossis LS, Suman OE, Herndon DN. The metabolic stress response to burn trauma: current understanding and therapies. Lancet. 2016; 388: 1417-26.

[64] Lukas G, Davies AR, Hilton AK, Pellegrino VA, Scheinkestel CD, Ridley E. Nutritional support in adult patients receiving extracorporeal membrane oxygenation. Crit Care Resusc. 2010; 12: 230-4.

[65] Jonckheer J, Spapen H, Malbrain MLNG, Oschima T, De Waele E. Energy expenditure and caloric targets during continuous renal replacement therapy under regional citrate anticoagulation. A viewpoint. Clin Nutr. 2020; 39: 353-7.

[66] Buck ML, Ksenich RA, Wooldridge P. Effect of infusing fat emulsion into extracorporeal membrane oxygenation circuits. Pharmacotherapy. 1997; 17: 1292-5.

[67] Buck ML, Wooldridge P, Ksenich RA. Comparison of methods for intravenous infusion of fat emulsion during extracorporeal membrane oxygenation. Pharmacotherapy. 2005; 25: 1536-40.

[68] Wang SL. Progress of burn research in metabolism and nutrition in China. Zhonghua Shao Shang Za Zhi. 2008; 24: 396-9.

[69] Sy E, Sklar MC, Lequier L, Fan E, Kanji HD. Anticoagulation practices and the prevalence of major bleeding, thromboembolic events, and mortality in venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. J Crit Care. 2017; 39: 87-96.

[70] Morabito S, Pistolesi V, Tritapepe L, Fiaccadori E. Regional citrate anticoagulation for RRTs in critically ill patients with AKI. Clin J Am Soc Nephrol. 2014; 9: 2173-88.

[71] Kindgen-Milles D, Brandenburger T, Dimski T. Regional citrate anticoagulation for continuous renal replacement therapy. Curr Opin Crit Care. 2018; 24: 450-4.

[72] Muellenbach RM, Kredel M, Kunze E, Kranke P, Kuestermann J, Brack A, et al. Prolonged heparin-free extracorporeal membrane oxygenation in multiple injured acute respiratory distress syndrome patients with traumatic brain injury. J Trauma Acute Care Surg. 2012; 72: 1444-7.

[73] Lee YY, Baik HJ, Lee H, Kim CH, Chung RK, Han JI, et al. Heparin-free veno-venous extracorporeal membrane oxygenation in a multiple trauma patient: a case report. Medicine (Baltimore). 2020; 99: e19070. doi: 10.1097/MD.0000000000019070.

[74] Mazzeffi MA, Tanaka K, Roberts A, Rector R, Menaker J, Kon Z, et al. Bleeding, thrombosis, and transfusion with two heparin anticoagulation protocols in venoarterial ECMO patients. J Cardiothorac Vasc Anesth. 2019; 33: 1216-20.

[75] Delmas C, Jacquemin A, Vardon-Bounes F, Georges B, Guerrero F, Hernandez N, et al. Anticoagulation monitoring under ECMO support: a comparative study between the activated coagulation time and the anti-Xa activity assay. J Intensive Care Med. 2020; 35: 679-86.

[76] Lai A, Demarest CT, Do-Nguyen CC, Ukita R, Skoog DJ, Carleton NM, et al. 72-hour in vivo evaluation of nitric oxide generating artificial lung gas exchange fibers in sheep. Acta Biomater. 2019; 90: 122-31.

[77] Cheng S, Xu S, Guo J, He Q, Li A, Huang L, et al. Risk factors of central venous catheter-related bloodstream infection for continuous renal replacement therapy in kidney intensive care unit patients. Blood Purif. 2019; 48: 175-82.

[78] Kim DW, Yeo HJ, Yoon SH, Lee SE, Lee SJ, Cho WH, et al. Impact of bloodstream infections on catheter colonization during extracorporeal membrane oxygenation. J Artif Organs. 2016; 19: 128-33.

[79] Evans O, Gowardman J, Rabbolini D, McGrail M, Rickard CM. In situ diagnostic methods for catheter related bloodstream infection in burns patients: a pilot study. Burns 2016; 42: 434-40.

[80] Hoff BM, Maker JH, Dager WE, Heintz BH. Antibiotic dosing for critically ill adult patients receiving intermittent hemodialysis, prolonged intermittent renal replacement therapy, and continuous renal replacement therapy: an update. Ann Pharmacother. 2020; 54: 43-55.

[81] Roberts JA, Joynt G, Lee A, Choi G, Bellomo R, Kanji S, et al. The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational SMARRT study. Clin Infect Dis. 2021; 72: 1369-78.

[82] Pistolesi V, Morabito S, Di Mario F, Regolisti G, Cantarelli C, Fiaccadori E. A guide to understanding antimicrobial drug dosing in critically ill patients on renal replacement therapy. Antimicrob Agents Chemother. 2019; 63: e00583-19.

[83] Eyler RF, Mueller BA. Antibiotic dosing in critically ill patients with acute kidney injury. Nat Rev Nephrol. 2011; 7: 226-35.

[84] Choi G, Gomersall CD, Tian Q, Joynt GM, Freebairn R, Lipman J. Principles of antibacterial dosing in continuous renal replacement therapy. Crit Care Med. 2009; 37: 2268-82.

[85] Li L, Li X, Xia Y, Chu Y, Zhong H, Li J, et al. Recommendation of antimicrobial dosing optimization during continuous renal replacement therapy. Front Pharmacol. 2020; 11: 786. doi: 10.3389/fphar.2020.00786.

[86] Shaw AR, Chaijamorn W, Mueller BA. We underdose antibiotics in patients on CRRT. Semin Dial. 2016; 29: 278-80.

[87] Zamoner W, de Freitas FM, Garms DS, de Oliveira MG, Balbi AL, Ponce D. Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients. Pharmacol Res Perspect. 2016; 4: e00280. doi: 10.1002/prp2.280.

[88] Roberts DM, Liu X, Roberts JA, Nair P, Cole L, Roberts MS, et al. A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. Crit Care. 2015; 19: 84. doi: 10.1186/s13054-015-0818-8.

[89] Ide T, Takesue Y, Ikawa K, Morikawa N, Ueda T, Takahashi Y, et al. Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy. Int J Antimicrob Agents. 2018; 51: 745-51.

[90] Chen W, Zhang D, Lian W, Wang X, Du W, Zhang Z, et al. Imipenem population pharmacokinetics: therapeutic drug monitoring data collected in critically ill patients with or without extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 2020; 64: e00385-20.